Zhongzhu Healthcare Holding Co (SHSE:600568) ROCE % : -5.18% (As of Sep. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Zhongzhu Healthcare Holding Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Zhongzhu Healthcare Holding Co's annualized ROCE % for the quarter that ended in Sep. 2024 was -5.18%.

Zhongzhu Healthcare Holding Co ROCE % Historical Data

The historical data trend for Zhongzhu Healthcare Holding Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhongzhu Healthcare Holding Co ROCE % Chart

Zhongzhu Healthcare Holding Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-8.24

1.13

-4.08

-21.53

-11.23

Zhongzhu Healthcare Holding Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															-1.24	-8.05	-4.19	-4.02	-5.18

Zhongzhu Healthcare Holding Co ROCE % Calculation

Zhongzhu Healthcare Holding Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-330.944	/	( ( (3712.889 - 463.272)	+	(3018.813 - 372.679) )	/ 2 )
	=	-330.944	/	( (3249.617	+	2646.134)	/ 2 )
	=	-330.944	/	2947.8755
	=	-11.23 %

Zhongzhu Healthcare Holding Co's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	-121.676	/	( ( (2708.089 - 337.883)	+	(2651.74 - 321.304) )	/ 2 )
	=	-121.676	/	( ( 2370.206	+	2330.436 )	/ 2 )
	=	-121.676	/	2350.321
	=	-5.18 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Zhongzhu Healthcare Holding Co (SHSE:600568) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Zhongzhu Healthcare Holding Co ROCE % Related Terms

Thank you for viewing the detailed overview of Zhongzhu Healthcare Holding Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhongzhu Healthcare Holding Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhongzhu Healthcare Holding Co Ltd (SHSE:600568) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

No. 1 Qinglu South Road, 8th Floor, Building 5, Yanlord Marina Center, Zhuhai, CHN, 519020

Website

http://www.zz600568.com

Zhongzhu Healthcare Holding Co Ltd produces and sells ophthalmic, antiviral, and anti-infective drugs in China. Its products include eye and nasal drops, injections, solid preparations, and other products. The product consists of Pearl Eye Drops, Sodium Cromolyn Eye Drops, Acyclovir Eye Drops, Hydroxybenzazole Hydrochloride Eye Drops, Acyclovir Dispersible Tablets, Gatifloxacin Tablets.

Executives

Ye Ji Ge	Director
Yan Jian	senior management
Xu De Lai	Director
Li Yong Jun	Director
Hu Hua Xia	Director
He Xiao Yan	senior management
Xiao Li Ling	Supervisors
Huang Xiang Ping	Director

Zhongzhu Healthcare Holding Co Headlines

No Headlines